Generic Name: Empagliflozin and metformin
Brand Name: Synjardy
Manufacturer: Boehringer Ingelheim (Canada) Ltd.
Indications: Diabetes mellitus (Type 2)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: October 25, 2016
Recommendation Type: Reimburse with clinical criteria and/or conditions